Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Greenspan: Significant differential effects of alendronate, estrogen, or combination therapy.... (0.10 sec) 

Significant differential effects of alendronate, estrogen, or combination therapy on the rate …

- annals.org [PDF] 
SL Greenspan, RD Emkey, HG Bone III, SR … - Annals of internal medicine, 2002 - Am Coll Physicians
Susan L. Greenspan, MD; Ronald D. Emkey, MD; Henry G. Bone III, MD; Stuart R.
Weiss, MD; Norman H. Bell, MD; Robert W. Downs Jr., MD; Clark McKeever, MD; Sam
S. Miller, MD; Michael Davidson, MD; Michael A. Bolognese, MD, PC; Anthony ...
Cited by 110 - Related articles - BL Direct - All 5 versions

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone …


JC Gallagher, PB Rapuri, G Haynatzki, JR … - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc
In a 5-yr randomized prospective study we examined the treatment effect of
estrogen replacement therapy/hormone replacement therapy (ERT/HRT), calcitriol,
ERT/HRT and calcitriol, or placebo for 3 yr and the effect of ...
Cited by 43 - Related articles - BL Direct - All 6 versions

Changes in bone density and turnover after alendronate or estrogen withdrawal


RD Wasnich, YZ Bagger, DJ Hosking, MR … - Menopause, 2004 - journals.lww.com
From 1 Radiant Research-Honolulu, Honolulu, HI; 2 Center for Clinical and Basic
Research, Ballerup, Denmark; 3 Nottingham City Hospital, Nottingham, UK; 4
Oregon Osteoporosis Center, Portland, OR; and 5 Merck Research ...
Cited by 37 - Related articles - BL Direct - All 3 versions

Withdrawal of hormone replacement therapy is associated with significant vertebral bone …


FA Tremollieres, JM Pouilles, C Ribot - Osteoporosis International, 2001 - Springer
Abstract. This study aimed to assess the changes in vertebral bone mineral
density (BMD) after cessation of hormone replacement therapy (HRT) in
postmenopausal women who had been treated on a long-term basis. Fifty ...
Cited by 58 - Related articles - BL Direct - All 3 versions

Bone mass response to discontinuation of long-term hormone replacement therapy: results …


GA Greendale, M Espeland, S Slone, R Marcus … - Archives of Internal Medicine, 2002 - Am Med Assoc
Background Accelerated bone loss after stopping hormone therapy (HRT) is
postulated to explain the lack of hip-fracture protection conferred by former
HRT use. The abbreviation HRT (traditionally standing for "hormone ...
Cited by 58 - Related articles - BL Direct - All 5 versions

Combination therapy with hormone replacement and alendronate for prevention of bone loss …


SL Greenspan, NM Resnick, RA Parker - Jama, 2003 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Therapy with ...
Cited by 92 - Related articles - BL Direct - All 7 versions

Effect of combined risedronate and hormone replacement therapies on bone mineral …

- endojournals.org
ST Harris, EF Eriksen, M Davidson, MP … - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc
At 12 months, significant (P < 0.05) increases from baseline in lumbar spine BMD
were observed in both treatment groups (HRT-only, 4.6%; combined
risedronate-HRT, 5.2%); the difference between the two groups was not ...
Cited by 129 - Related articles - BL Direct - All 6 versions

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density …


E Barrett-Connor, LE Wehren, ES Siris, P … - Menopause, 2003 - journals.lww.com
From the 1 University of California, San Diego, La Jolla, CA; 2 University of
Maryland, Baltimore, MD; 3 Columbia University College of Physicians and
Surgeons, New York, NY; 4 Colorado Center for Bone Research, Lakewood, CO; ...
Cited by 53 - Related articles - BL Direct - All 3 versions

Alendronate and estrogen effects in postmenopausal women with low bone mineral density

- endojournals.org
HG Bone, SL Greenspan, C McKeever, N Bell, … - Journal of Clinical Endocrinology & Metabolism, 2000 - Endocrine Soc
The bisphosphonate alendronate and conjugated equine estrogens are both widely
used for the treatment of postmenopausal osteoporosis. Acting by different
mechanisms, these two agents decrease bone resorption and thereby increase ...
Cited by 224 - Related articles - BL Direct - All 7 versions

Rapid loss of hip fracture protection after estrogen cessation: evidence from the National …


J Yates, E Barrett-Connor, S Barlas, YT Chen, … - Obstetrics & Gynecology, 2004 - journals.lww.com
From *Merck and Company, Inc, Upper Gwynedd, Pennsylvania; †University of
California, San Diego, La Jolla, California; ‡Colorado Center for Bone
Research, Lakewood, Colorado; and §Columbia University College of ...
Cited by 44 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google